1. Anti-cancer fatty-acid derivative induces autophagic cell death through modulation of PKM isoform expression profile mediated by bcr-abl in chronic myeloid leukemia. Issue 1 (28th April 2015) Authors: Shinohara, Haruka; Taniguchi, Kohei; Kumazaki, Minami; Yamada, Nami; Ito, Yuko; Otsuki, Yoshinori; Uno, Bunji; Hayakawa, Fumihiko; Minami, Yosuke; Naoe, Tomoki; Akao, Yukihiro Journal: Cancer letters Issue: Volume 360:Issue 1(2015) Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Asciminib vs bosutinib in CML patients pretreated with ≥2 tyrosine kinase inhibitors: Results from the Japanese subgroup analysis of ASCEMBL study. (27th September 2022) Authors: Yuda, Junichiro; Doki, Noriko; Matsuoka, Hiroshi; Yokota, Takafumi; Tomita, Akihiro; Takahashi, Naoto; Matsumura, Itaru; Kubo, Kohmei; Goto, Tatsunori; Kirito, Keita; Maki, Akio; Aoki, Makoto; Allepuz, Alex; Minami, Yosuke Journal: Cancer medicine Issue: Volume 12:Number 3(2023) Page Start: 2990 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical implications of combination therapy with quizartinib and craniospinal irradiation for refractory acute myeloid leukemia positive for FMS‐like tyrosine kinase 3‐internal tandem duplication with central nervous system involvement. Issue 2 (4th February 2022) Authors: Suga, Makiko; Fukushima, Kentaro; Ueda, Tomoaki; Arai, Yasuyuki; Nakagawa, Shunsaku; Minami, Yosuke; Toda, Jun; Hino, Akihisa; Fujita, Jiro; Yokota, Takafumi; Hosen, Naoki Journal: Clinical case reports Issue: Volume 10:Issue 2(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial. Issue 12 (December 2015) Authors: Imagawa, Jun; Tanaka, Hideo; Okada, Masaya; Nakamae, Hirohisa; Hino, Masayuki; Murai, Kazunori; Ishida, Yoji; Kumagai, Takashi; Sato, Seiichi; Ohashi, Kazuteru; Sakamaki, Hisashi; Wakita, Hisashi; Uoshima, Nobuhiko; Nakagawa, Yasunori; Minami, Yosuke; Ogasawara, Masahiro; Takeoka, Tomoharu; Akasa... Journal: Lancet Issue: Volume 2:Issue 12(2015) Page Start: e528 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Feasibility and clinical utility of comprehensive genomic profiling of hematological malignancies. Issue 8 (17th June 2022) Authors: Fukuhara, Suguru; Oshikawa‐Kumade, Yuji; Kogure, Yasunori; Shingaki, Sumito; Kariyazono, Hirokazu; Kikukawa, Yoshiya; Koya, Junji; Saito, Yuki; Tabata, Mariko; Yoshifuji, Kota; Mizuno, Kota; Miyagi‐Maeshima, Akiko; Matsushita, Hiromichi; Sugiyama, Masanaka; Ogawa, Chitose; Inamoto, Yoshihiro; Fuk... Journal: Cancer science Issue: Volume 113:Issue 8(2022) Page Start: 2763 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Heme‐related molecules induce rapid production of neutrophil extracellular traps. Issue 11 (28th May 2014) Authors: Kono, Mari; Saigo, Katsuyasu; Takagi, Yuri; Takahashi, Takayuki; Kawauchi, Sawako; Wada, Atsushi; Hashimoto, Makoto; Minami, Yosuke; Imoto, Shion; Takenokuchi, Mariko; Morikawa, Takashi; Funakoshi, Kunihiro Journal: Transfusion Issue: Volume 54:Issue 11(2014) Page Start: 2811 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Iron‐chelating agent, deferasirox, inhibits neutrophil activation and extracellular trap formation. (October 2016) Authors: Kono, Mari; Saigo, Katsuyasu; Yamamoto, Shiori; Shirai, Kohei; Iwamoto, Shuta; Uematsu, Tomoko; Takahashi, Takayuki; Imoto, Shion; Hashimoto, Makoto; Minami, Yosuke; Wada, Atsushi; Takenokuchi, Mariko; Kawano, Seiji Journal: Clinical and experimental pharmacology and physiology Issue: Volume 43:Number 10(2016:Oct.) Page Start: 915 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Patients with B-cell malignancies experience reduced antibody responses with class switching defect following BNT162b2 SARS-CoV-2 vaccination. Issue 1 (January 2023) Authors: Nakagama, Yu; Chi, Sung-Gi; Minami, Yosuke; Watanabe, Reiko; Yamagishi, Michiteru; Atsuko, Uno; Kido, Yasutoshi Journal: Journal of infection and chemotherapy Issue: Volume 29:Issue 1(2023) Page Start: 112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Perturbation of energy metabolism by fatty-acid derivative AIC-47 and imatinib in BCR-ABL-harboring leukemic cells. Issue 1 (1st February 2016) Authors: Shinohara, Haruka; Kumazaki, Minami; Minami, Yosuke; Ito, Yuko; Sugito, Nobuhiko; Kuranaga, Yuki; Taniguchi, Kohei; Yamada, Nami; Otsuki, Yoshinori; Naoe, Tomoki; Akao, Yukihiro Journal: Cancer letters Issue: Volume 371:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Phase I study of glasdegib (PF‐04449913), an oral smoothened inhibitor, in Japanese patients with select hematologic malignancies. Issue 8 (19th June 2017) Authors: Minami, Yosuke; Minami, Hironobu; Miyamoto, Toshihiro; Yoshimoto, Goichi; Kobayashi, Yukio; Munakata, Wataru; Onishi, Yasushi; Kobayashi, Masahiro; Ikuta, Mari; Chan, Geoffrey; Woolfson, Adrian; Ono, Chiho; Shaik, Mohammed Naveed; Fujii, Yosuke; Zheng, Xianxian; Naoe, Tomoki Journal: Cancer science Issue: Volume 108:Issue 8(2017) Page Start: 1628 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗